Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus twice-daily phenobarbital for neonatal seizures
IRCT20090813002342N12Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of phenobarbital in seizure (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Phenobarbital plasma concentration and Number of new seizures. Started Sep 2017; status: completed.
02
Drugs
phenobarbital
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT20090813002342N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090813002342N12.